Page last updated: 2024-12-06

picloxydine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

picloxydine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5748610
CHEBI ID135768
MeSH IDM0046665

Synonyms (27)

Synonym
D07415
picloxydine (inn)
5636-92-0
picloxydine
CHEBI:135768
picloxidina
picloxydinum
unii-4yc2py3aeu
picloxidina [inn-spanish]
4yc2py3aeu ,
picloxydinum [inn-latin]
picloxydine [inn:ban:dcf]
einecs 227-084-3
1,1'-(1,4-piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine)
picloxydine [inn]
picloxydine [who-dd]
picloxydine [mi]
1,4-piperazinedicarboximidamide, n,n''-bis[[(4-chlorophenyl)amino]iminomethyl]-
1,1'-[1,4-piperazinediylbis(imidocarbonyl)]bis[3-(p-chlorophenyl)guanidine]
n-[(4-[([(4-chloroanilino)(imino)methyl]amino)(imino)methyl]-1-piperazinyl)(imino)methyl]-n'-(4-chlorophenyl)guanidine #
YNCLPFSAZFGQCD-UHFFFAOYSA-N
CS-7157
HY-U00120
DB13607
n1,n4-bis(n-(4-chlorophenyl)carbamimidoyl)piperazine-1,4-bis(carboximidamide)
DTXSID50863586
AKOS040734779
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]